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Abstract
Utility of the pyridazine motif is growing in popularity as pharmaceutical and
agrochemical agents. The detection and structural characterisation of such
materials is therefore imperative for the successful development of new
products. Signal amplification by reversible exchange (SABRE) offers a route
to dramatically improve the sensitivity of magnetic resonance methods, and
we apply it here to the rapid and cost-effective hyperpolarisation of substituted
pyridazines. The 33 substrates investigated cover a range of steric and elec-
tronic properties and their capacity to perform highly effective SABRE is
assessed. We find the method to be tolerant to a broad range of electron donat-
ing and withdrawing groups; however, good sensitivity is evident when steric
bulk is added to the 3- and 6-positions of the pyridazine ring. We optimise the
method by reference to a disubstituted ester that yields signal gains of
>9000-fold at 9.4 T (>28% spin polarisation).
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1 | INTRODUCTION
Pyridazine is a dinitrogen containing aromatic heterocy-
cle that contains two sp2-hybridised nitrogen atoms
within a six-membered ring. Whilst being isosteric with
benzene, it offers increased possibilities for molecular
interactions, higher electron density, lower LogP values
and improved crystallinity. This has resulted in its use
increasing in both pharmaceutical and agrochemical
industries.[1] Indeed, the replacement of phenyl rings
within drug molecules has led to several hundred articles
dealing with bioactive pyridazines that belong to almost
all therapeutic classes in the last 15 years alone.[2] As
such, pyridazine has been described as a ‘privileged
structure’ within the field of medicinal chemistry.[3] Most
recent examples have focused on the synthesis and evalu-
ation of fused bi- and tri-cyclic pyridazines such as
imidazo,[2] pyrrolo[4] and thienopyridazines.[5]
With such prevalence of pyridazines in medicinal and
agricultural chemistry, routes to their rapid and accurate
detection and structural determination are necessary.
Nuclear magnetic resonance (NMR) is one of the most
widely used methods in the analytic sciences and offers
unique insight into molecular structure, activity and
environment. However, when compared with other ana-
lytical techniques, such as mass spectrometry or infrared
spectroscopy, the required sample size and concentration
are much higher. This is due to the lower sensitivity of
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NMR that is caused by very small population differences
between the magnetic state energy levels that the method
probes. Classically, this insensitivity is overcome by sig-
nal averaging and increased concentrations, which has
time and cost implications. However, this sensitivity chal-
lenge will hinder the ability of NMR to rapidly detect
transient intermediates or trace impurities.
NMR hyperpolarisation offers an attractive solution
by creating magnetic state energy level populations that
deviate from the Boltzmann distribution.[6] This has led
to the development of methods with sensitivity gains that
are many orders of magnitude higher than could be
achieved using conventional NMR. These large signals
have been widely exploited for probing reaction
mechanisms,[7] detection of low concentration species[8]
and the in vivo quantification of anatomy[9] and metabo-
lism[10] amongst others. A number of methods for creat-
ing the hyperpolarised species are known with spin
exchange optical pumping (SEOP),[11] dynamic nuclear
polarisation (DNP)[6a,12] and parahydrogen induced
polarisation (PHIP)[6a,13] being the most common.
Signal amplification by reversible exchange
(SABRE)[14] is a PHIP method that derives its hyp-
erpolarised spin order from the singlet state of hydrogen,
parahydrogen (p-H2). SABRE typically utilises an iridium
N-heterocyclic catalyst[15] that reversible binds p-H2, as
hydride ligands, and a substrate molecule such that spin
polarisation is transferred through the temporarily
formed J-coupling network.[16] Since its first report in
2009, SABRE has received wide attention from the
research community, and the method and its applications
have been recently reviewed in detail.[17]
Pyridazine has previously been shown to be
amenable to SABRE hyperpolarisation, and the
mechanism for the formation of the active SABRE
catalyst is well defined.[18] When [IrCl (COD)(IMes)]
(where COD = 1,5-cyclooctadience and IMes = 1,3-bis
(2,4,6-trimethylphenyl)imidazol-2-ylidene) is reacted
with H2 in the presence of pyridazine at 298 K, [Ir
(H)2(IMes)(pyridazine)3]Cl is formed which undergoes
reversible ligand exchange in methanol-d4. Additionally,
a hapotropic shift between the two nitrogen atoms in the
ring is also observed using EXSY. When this sample was
exposed to p-H2 (3 bar), a ca. 400-fold
1H signal gain was
observed at 9.4 T for its two proton resonances after
polarisation transfer at 65 G. The use of selective deutera-
tion enabled the SABRE polarisation level to increase
such that 3,5-d2-pyridazine yields polarisation levels of
greater than 22% (>7000-fold signal gain at 9.4 T) in con-
junction with T1 lifetimes that approach 3 min when a
deuterated catalyst and 5 bar pressure of p-H2 were
employed.[19] The high symmetry of the pyridazine motif
has also been exploited for the creation of long-lived
magnetic states that allow detection of a 1H NMR signal
15 min after its creation.[20] Additionally, SABRE hyper-
polarisation of its 13C and 15N nuclei with in pyridazine
has also been reported.[21]
Here, we wish to report the effects of pyridazine func-
tional group substitution on the SABRE derived 1H NMR
enhancements and T1 relaxation lifetimes. Over 30 mono
and disubstituted pyridazines are investigated that
encompass a range of steric and electronic properties in
this study. This allows us to draw conclusions as to what
are the optimum substitution patterns, in addition to
defining the functional group tolerance on the SABRE
effect.
2 | RESULTS AND DISCUSSION
Our examination of the effects of pyridazine substitution
began with the study of mono substituted substrates prior
to building in complexity. The 3-Substituted pyridazines
2–7 shown in Table 1 were purchased or synthesised as
described in the supporting information. NMR tubes
equipped with a J. Young's Tap were filled with a solu-
tion containing [IrCl (COD)(IMes)] (5 mM), substrate
(20 mM) in methanol-d4 and exposed to H2 (3 bar). After
1 h at room temperature, the samples were analysed by
1H NMR spectroscopy for the formation of new hydride
containing complexes. For comparison, we also recorded
the 1H NMR spectrum of a sample containing pyridazine
1, which showed a single hydride containing complex
with a resonance at δH –21.49 that is consistent with
[Ir(H)2(IMes)(pyridazine)3]Cl as previously reported in
the literature.[18] The headspace of this sample is then
replaced with 3 bar p-H2 (>99% enrichment) and manu-
ally shaken in a 70 G polarisation transfer field, prior to
rapid insertion into a 9.4 T NMR spectrometer and a 1H
NMR spectrum was immediately recorded (full experi-
mental details are available in the supporting informa-
tion). This 1H NMR spectrum showed per proton signal
enhancements of 316- and 472-fold for the ortho and
meta resonances of pyridazine after SABRE polarisation
transfer at 70 G after quantification. T1 relaxation values
of 29.1 s for the ortho (H3/6) resonance and 26.6 s for the
meta (H4/5) resonance were observed for this sample.
Our first step in adding complexity to the pyridazine
substrate was through the introduction of a methyl group
adjacent to the nitrogen atom in order to investigate
steric influence on SABRE hyperpolarisation. In analo-
gous 2-picoline, the methyl group inhibits SABRE when
using the [IrCl (COD)(IMes)] precatalyst[22]; however,
this has been recently overcome through the use of a bid-
entate PHOX ligand and up to 132-fold signal gains are
reported.[23] In contrast, 3-methylpyridazine 2, performed
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1H SABRE signal gain
at 9.4 T (% polarisation)
T1 relaxation time at 298 K
measured at 9.4 T/s
−21.49 H3/6-472 ± 24 (1.5%) H3/6-29.1
H4/5-316 ± 42 (1.0%) H4/5-26.6
−21.59 H4-758 ± 48 (2.4%) H4-21.4
H5-1161 ± 101 (3.6%) H5-23.0
H6-1177 ± 76 (3.7%) H6-29.4
−21.63 H4-648 ± 68 (2.0%) H4-28.2
H5-884 ± 87 (2.8%) H5-24.5
H6-759 ± 64 (2.4%) H6-31.0
−21.54 H4-99 ± 11 (0.3%) H4-12.1
H5-260 ± 32 (0.8%) H5-16.3
H6-273 ± 54 (0.9%) H6-17.6
−21.52 H4-1266 ± 105 (4.0%) H4-15.4
H5-553 ± 86 (1.7%) H5-20.8
H6-936 ± 65 (2.9%) H6-27.9
−21.42 H4-307 ± 31 (1.0%) H4-22.2
H5-84 ± 14 (0.3%) H5-13.6
H6-252 ± 18 (0.8%) H6-21.7
−20.68, −23.03 (JHH = 7.3 Hz) H4-3 ± 1 (0.01%) H4-17.4
H5-6 ± 2 (0.02%) H5-25.8
H6-6 ± 1 (0.02%) H6-27.2
−
[a] H3-613 ± 31 (1.9%) H3-27.2
H5-354 ± 19 (1.1%) H5-20.8
H6-541 ± 12 (1.7%) H6-24.2
−
[a] H3-564 ± 35 (1.8%) H3-45.4
H5-374 ± 48 (1.2%) H5-15.0
H6-652 ± 52 (2.0%) H6-17.4
−
[a] H3-862 ± 65 (2.7%) H3-57.4
H5-589 ± 71 (1.8%) H5-18.4
H6-778 ± 32 (2.4%) H6-18.0
(Continues)
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well under SABRE conditions and the signal gains were
improved when compared with 1. Indeed, 1H signal
enhancements for the H4, H5 and H6 resonances were
758-, 1161- and 1177-fold, respectively. A 145-fold signal
gain was also observed for the resonance of the methyl
proton. Only a single hydride containing species could be
detected under both PHIP and low temperature
NMR studies with a hydride resonance at δH −21.59.
Therefore, we suggest that each of the three 2 ligands in
[Ir(H)2(IMes)(2)3]Cl bind through the N1 atom and other
potential regioisomers either do not form or are present
at too low concentrations to be detected. This is likely to
be due to the steric influence of the methyl group
which may hinder binding through the N2 atom.
3-Methoxypyridazine 3 also formed a single hydride con-
taining complex and its hydride resonance shifted to δH
−21.63 in line with the increased electron donating
capacity of this ligand. After SABRE polarisation transfer
under analogous conditions, a 759-fold signal gain was
observed for the H6 resonance. This is >2 times the
analogous signal gain for 1, although it is a reduction in
that observed relative to 2. Its T1 relaxation times are
comparable with that of 1.
Further complexity was introduced by utilising the
hydroxymethyl functionality in 4, and this resulted in a
significantly reduced SABRE signal enhancements. Now,
the maximum signal gain was 273-fold for the H6
resonance. Although the major hydride containing spe-
cies remains that of [Ir(H)2(IMes)(4)3]Cl (δH −21.54), an
additional complex with broad hydride resonances at δH
−20.68 and −30.69 also appears, which could be due to
bidentate binding of 4 in the equatorial plane through its
N and O donor atoms. The broadness of these resonances
indicates rapid hydride loss to form H2, a process which
would quickly consume the available p-H2 thereby
reducing the observed signal gains. Additionally, its T1
values for H4, H5 and H6 were 12.1, 16.3 and 17.6 s,
respectively, and therefore shorter than those for
3-methylpyridazine 2.
Next, we probed the effect of introducing electron-
withdrawing substituents into the three position with
substrates 5–7. 3-Chloropyridazine 5 forms a single
hydride containing complex with a resonance δH −21.52
and performs well under SABRE. A signal gain for its H4
proton of 1266-fold was observed, and its H5 and H6 res-
onances showed signal enhancements of 552- and
935-fold, respectively. T1 values of 15.4, 20.8 and 27.9 s
were also measured at 9.4 T. This indicates that the
SABRE of monosubstituted pyridazines is tolerant to
both electron-rich and electron-deficient ring systems.
Methyl-3-pyridazinecarboxylate 6 did not yield as high
signal enhancements as 5. Instead, a maximum of
307-fold signal gain was quantified for its H4 resonance.
The dominant hydride containing complex gives a
resonance at δH −21.52; however, a minor product that
has hydride resonances at δH −20.12 and −29.42 also
appears under PHIP conditions.
In contrast, 3-pyridazinecarbonitrile 7 does not form
a dihydride-symmetric active catalyst and instead yields a
product with inequivalent hydride resonances at δH
−20.68 and −23.03 that share a J-coupling of 7.3 Hz. As
the binding of nitrile ligands to form an active SABRE
catalyst is well established,[24] we attribute these hydride
resonances to the complex whereby one molecule of 7 is
bound through the N1 atom and the other is bound
through its nitrile group in the equatorial plane.
Additionally, a minor product with hydride resonances at
δH −20.8 and −21.9 appears under PHIP conditions,
which is likely to be due to the regioisomeric binding of
7 in the axial position. In this case, poor SABRE enhance-
ment results and a maximum 6-fold 1H NMR signal
enhancement was quantified at 9.4 T. The T1 values for
7 are comparable with that of pyridazine 1.
Next, we considered the effects of 4-substituted
pyridazines 8–11. 4-Methylpyridazine 8 showed good
polarisation levels of 613-, 354- and 541-fold for its H3,
H5 and H6 resonances, respectively. In contrast






1H SABRE signal gain
at 9.4 T (% polarisation)
T1 relaxation time at 298 K
measured at 9.4 T/s
−
[a] H3-1204 ± 86 (3.8%) H3-69.6
H5-754 ± 75 (2.4%) H5-12.2
H6-897 ± 101 (2.8%) H6-24.2
Note: Superscript [a] indicates a complex hydride region in the 1H NMR spectrum that contains a minimum of five products.
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multiple hydride-containing complexes on reaction with
[IrCl (COD)(IMes)] in the presence of H2. Cooling the
sample to 243 K reveals >5 hydride containing complexes
with resonances between δH –21.25 and −21.42. Because
the methyl group of 8 has a reduced steric influence on
the ligation to the metal centre when compared with 2, it
is now possible that the regioisomeric complexes, where
binding can occur through either the substrates N1 or N2
atoms, lie much closer in energy than for the case of 2.
Statistically, this would lead to the possibility of six
TABLE 2 Summary of SABRE hyperpolarisation and T1 relaxation times of 3,6-disubstituted pyridazines
Substrate
Hydride resonance for [Ir
(H)2(IMes)(sub)3]cl at 298 K
1H SABRE signal gain at 9.4 T
(% polarisation)
T1 relaxation time at 298 K
measured at 9.4 T
−21.50 H4/5–492 ± 35 (1.5%) H4/5–58.2










[b] H4–117 ± 21 (0.4%) H4–16.2
H5–31 ± (0.1%) H5–15.2
−
[b] H4–12 ± 3 (0.03%) H4–26.7
H5–3 ± 1 (0.01%) H5–25.8
Note: Superscript [a] indicates chemical shift measured at 243 K. Superscript [b] indicates a complex hydride region in the 1H NMR spectrum that contains
multiple products.
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regioisomers of [Ir(H)2(IMes)(8)3]Cl being present in
solution.
A complex hydride region is also present after forma-
tion of the active SABRE catalysts of 4-acetylpyridazine 9.
Strong SABRE performance is still present and a signal
gain of 564-fold for its H3 resonance is detected. Addi-
tionally, the T1 value of the H3 resonance is increased to
45.7 s, which can be attributed to the lack of spin–spin
routes to relaxation for this isolated proton. When a
methyl ester is introduced into the 4-position to give 11
an improvement in signal gain is noted. The H3, H5 and
H6 resonances of 11 exhibit signal gains of 862-, 589- and
778-fold, respectively. Additionally, a 57.4 s T1 relaxation
time is quantified for its H3 resonance, which is again
isolated from other spins in the substrate due to the pres-
ence of the ester. Deuteration of the methyl group to
form d3–11 significantly improved its SABRE polarisation
levels. Now 1204-, 754- and 897-fold signal gains were
quantified for the H3, H4 and H6 resonances, respec-
tively. The T1 relaxation values also increase, and the
isolated H3 proton now has a value that is 69.6 s.
In order to increase the substrate complexity, a
second substituent was added onto the pyridazine ring.
First, symmetrical 3,6-substituted pyridazines 11–13 were
investigated followed by unsymmetrical variants 14–18 as
shown in Table 2. 3,6-d2-Pyridazine (3,6-d2–1) gave
higher signal enhancements than its protio counterpart
(1) with a 492-fold per proton signal gain for the
remaining H4/5 position. Additionally, the T1 relaxation
time is also increased to 58.2 s from 26.6 s due to a reduc-
tion in spin–spin interactions within the substrate.
3,6-Dimethylpyridazine (11) presents an increased steric
challenge when compared with its mono-substituted
counterpart 2. Although an active SABRE complex forms
with a hydride resonance at δH −21.61, a significant
reduction in polarisation transfer results. After SABRE
transfer at 70 G, a 129-fold signal gain is observed for its
H4/5 proton resonance which is ca. 50% of that which
was quantified for 1. Similarly, 3,6-dichloropyridazine 12
also forms a SABRE complex; however, its hydride reso-
nance only becomes visible at 243 K and gives a peak at
δH −24.45. At 298 K, a very broad hydride resonance is
detected that indicates rapid ligand loss. Now, no 1H
SABRE polarisation is detected after polarisation transfer
over a range of magnetic fields (0.5–120 G). This is in
contrast to the reported 15N signal gain of 12 000-fold
that is achieved at 8.5 T.[21c] We suggest that the faster
ligand dissociation is better matched for the strong 2JHN
coupling between the substrate and hydride ligands in
the active complex when compared with the weaker 5JHH
coupling.
No SABRE transfer is observed for 3,6-
dimethoxypyridazine (13) after SABRE polarisation
transfer, and no evidence of any hydride containing com-
plexes could be obtained at either low temperature or
under PHIP conditions. Unsymmetrical substrates 14–16
also yielded no SABRE enhancements in their 1H NMR
spectra after polarisation transfer. This indicates that the
steric influence of the 3,6-disubstituted substrates is not
conducive to polarisation transfer. Finally, we were able
to obtain weak SABRE enhancements for 3-chloro-
6-aminopyridazine 17 and 3-chloro-6-cyanopyridazine
18. In both cases, multiple hydride resonances are pre-
sent in the 1H NMR spectrum, which reflects their multi-
ple binding modalities. 3-Chloro-6-aminopyridazine 17
showed SABRE derived signal gains of 112-fold for the
H5 signal and 61-fold for its H4 resonance. Its 1H NMR
spectrum reveals the presence of two dominant hydride
containing complexes: first, a symmetric complex with a
hydride resonance at δH −22.1 and second with broad
resonances at δH −21.8 and −29.7. These complexes are
formed in a 1:5 ratio and can be accounted for by binding
through both the pyridazine ring nitrogen and also the
aromatic amine.[25] For 18, the hydride signals are much
more complex with ca. 4 hydride containing complexes
being formed, which may arise due to the ability for
binding through both the ring nitrogen and nitrile group.
The SABRE-derived polarisation transfer to 18 was signif-
icantly lower, and a maximum 12-fold signal gain was
quantified.
Overall, the signal enhancements for the 3,6-
disubstituted pyridazines are significantly lower than
those of the monosubstituted pyridazines. This is like to
be due to a combination of effects. Firstly, the occupation
of the ortho position increases the steric demand around
the metal centre, which will either inhibit the formation
of the active SABRE complex or significantly reduce the
lifetime of the active catalyst. Secondly, as the ortho sites
are occupied, the SABRE process utilises the weaker 5J
coupling from the hydride to the meta proton which may
lead to less efficacious polarisation transfer.
The investigation was then extended to 4,5-
disubstituted pyridazines which were synthesised by the
well-established[26] reverse electron demand Diels–Alder
reaction as detailed in the supporting information. Expo-
sure of a methanol-d4 solution containing [IrCl(COD)
(IMes)] (5 mM), substrate 19–29 (20 mM) to H2 (3 bar)
led to the formation of single hydride containing com-
plexes in all cases with their resonances appearing
between δH −20.89 and −22.12 for each of the substrates.
We attribute these resonances to the respective product
of type [Ir(H)2(IMes)(sub)3)]Cl.
[18] When the sample was
exposed to p-H2 (3 bar) in a ca. 70 G polarisation transfer
field, significant improvements in their 1H NMR signal
enhancements were observed when compared
with the corresponding thermally polarised spectra.
6 RAYNER ET AL.





1H SABRE signal gain
at 9.4 T (% polarisation)
T1 relaxation time
at 298 K measured at 9.4 T
−21.59 H3/6-1871 ± 201 (5.8%) H3/6-85.8
−22.12 H3/6-998 ± 78 (3.1%) H3/6-7.1
−21.00 H3/6-128 ± 18 (0.4%) H3/6-8.2
−21.15 H3/6-823 ± (2.6%) H3/6-13.8
−21.15 H3/6-1365 ± 145 (4.3%) H3/6-33.2
−21.03 H3/6-878 ± 76 (2.7%) H3/6-84.3
−20.89 H3/6-1647 ± 79 (5.1%) H3/6-120.8
−20.84 H3/6-1134 ± 124 (3.5%) H3/6-83.4
(Continues)
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4,5-d2-Pyridazine 4,5-d2–1 gave a 3480-fold per proton
signal enhancement for its ortho resonance. Additionally,
a T1 relaxation time of 85.8 s, which is longer than that of
the corresponding 3,6-d2-pyridazine 3,6-d2–1, however, is
shorter than that of 3,5-d2-pyridazine isotopologue which
has been reported previously.[19] Introduction of electron
donating methoxy groups (19) into the 4,5-positions gave
signal enhancements of 998-fold at 9.4 T for the ortho
protons of 19. Disappointingly, its T1 relation time signifi-
cantly shortens to just 7.1 s. We propose this could be
due to intramolecular dipole–dipole coupling between
protons. Trimethylsilyl derivative 20 shows significantly
reduced SABRE activity and just a 129-fold 1H NMR
signal gain was quantified at 9.4 T. Polarisation transfer
was also attempted into its 29Si nuclei; however, no signal
gain was observed after polarisation transfer at a range
of fields from 0.5 G to 120 G. This is in contrast
to other silyl-derived substrates that showed SABRE
polarisation transfer to 29Si is possible via the adjacent 1H
nuclei at 25 G.[27] The 1H T1 value for the ortho
resonances was measured to be just 11.1 s. Compara-
tively, 4,5-Diphenylpyridazine 21 showed good SABRE
transfer, and a 823-fold signal gain was quantified at
9.4 T. However, its T1 value was just 13.8 s. Synthesis of
its selectively deuterated isotopologue yielded an
improvement in both SABRE polarisation transfer and
the T1 value of the remaining proton resonance. Indeed,
d10–21 gave a 1365-fold signal gain at 9.4 T in conjunc-
tion with a relaxation time of 33.2 s were quantified.
When electronegative atoms are placed in the
4,5-positions, good SABRE enhancement is still evident.
Thus, when 4,5-dichloropyridazine 22 reduced the signal
gain was 878-fold and its T1 value increased to 84.3 s.






1H SABRE signal gain
at 9.4 T (% polarisation)
T1 relaxation time
at 298 K measured at 9.4 T
−20.89 H3/6-465 ± 67 (1.5%) H3/6-68.4
−20.87 H3/6-1256 ± 207 (3.9%) H3/6-94.6
−21.20 H3/6-421 ± 32 (1.3%) H3/6-39.2
−21.20 H3/6-325 ± 54 (1.0%) H3/6-12.9
−21.24 H3/6-237 ± 43 (0.7%) H3/6-5.1
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with dimethyl ester 23 yielding a 1647-fold signal gain for
its ortho resonance, and the relaxation time was to
120.1 s. This is equivalent to 5.1% polarisation at 9.4 T.
As this diester derivative showed strong polarisation
transfer and long magnetic lifetimes, we wished to further
probe the effect of the ester moiety on the SABRE effect.
Therefore, diethyl ester 24 was synthesised and subject to
analogous SABRE testing. After interrogation at 9.4 T a
1134-fold signal enhancement resulted. This is a reduction
when compared with dimethyl ester 23 and a reduction in
T1 value from 120.8 to 83.4 s is also noted. Introduction of
isopropyl esters (25) further reduces both the SABRE
signal gains and the T1 values. These T1 effects can be
quantified by working out an enhancement value at the
point of creation of the hyperpolarised state. Assuming this
T1 value remains constant for 5 s during the moving into
the measurement field where the polarisation level is
quantified, we estimate that initial polarisation levels of
ca. 1700-, 1250- and 500-fold for 23, 24 and 25 respectively
result. This indicates that there is a steric effect taking
place during the SABRE process even in the remote
4,5-positions. Breaking the symmetry of the molecule
through the use of one methyl ester and one ethyl ester in
26 returns the substrate to high average SABRE enhance-
ments of 1256. The individual enhancements for H3 and
H6 could not be determined due to peak overlap. The aver-
age T1 on the remaining proton sites is now 94.6 s.
The introduction of amide groups into the
4,5-positions reduces the SABRE performance of the
pyridazine molecules 27–29 when compared with
dimethyl ester 23. Additionally, the T1 values for the
amide derivatives are all significantly smaller than the
ester counterparts, which may reduce the detected
polarisation level. A similar T1 analysis reveals that at the
point of creation, the polarisation levels for 27, 28 and 29
would be ca. 500-, 500- and 550-fold, respectively. These
values are all comparable with one another and yet three
times smaller than those calculated for dimethyl ester 23.
Such an effect is likely to be due to an increase in the
ligand exchange rate relative to that of the ester derivate
and away from that which has been predicted to be opti-
mal by Barskiy.[28] Given the previously reported
studies on SABRE as a function of electronic and steric
NHC impact, such behaviour is not unexpected.[15]
Analysis of the reported values for nicotinamide and
methyl nicotinate reveals a similar 3-fold reduction in
signal enhancement where electronic effects are clearly
dominant.[19]
With the success of SABRE hyperpolarisation of
dimethyl ester 23, we began to explore methods to further
optimise its hyperpolarisation and explore the effects of
other carbonyl containing substrates. First, we investi-
gated the effect of increasing the concentration of 23 on
the resulting SABRE signal gains (Figure 1). We found
FIGURE 1 Optimisation of SABRE hyperpolarisation of 23. (a) Effect of increasing the equivalents of substrate on the SABRE
hyperpolarisation of 23. (b) Effect of changing the N-heterocyclic carbene (NHC) ligand in the precatalyst of type [IrCl (COD)(NHC)] on the
SABRE hyperpolarisation of 23. (c) Structures of NHC ligands used in the study
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that four equivalents of 23 was optimal and increasing
beyond this catalyst loading led to a reduction in
polarisation efficacy. This is consistent with the effects of
diluting the finite available polarisation from p-H2
through an increased number of substrate spins.
The nature of the N-heterocyclic carbene (NHC) in
the SABRE precatalyst can have a profound effect on the
signal enhancement.[15b,29] Therefore, we screened a
series of precatalysts of type [IrCl(COD)(NHC)], which
have been shown to modulate the rate of ligand loss
through increased steric effects.[29b] When using [IrCl
(COD)(SIMes)] as the precatalyst an increased signal
enhancement of 3788 ± 132-fold was observed for 23,
which is over two times larger than that seen with [IrCl
(COD)(IMes)]. However, further utilisation of the larger
IPr ligand led to a reduction in signal enhancement to
1542 ± 154-fold. Therefore, we can conclude that the
optimal conditions for the polarisation of 23 are [IrCl
(COD)(SIMes)] (5 mM), 23 (20 mM) in methanol-d4, and
these conditions would be applied to further studies on
the 4,5-dicarbonyl pyridazines.
We began with the synthesis of its isotopologue,
d6–23, with a view to extending its relaxation lifetime
and increasing its SABRE efficacy. After subjection of
d6–23 to the optimised SABRE conditions ([IrCl(COD)
(SIMes)] (5 mM), d6–23 (20 mM) in methanol-d4), a
9177-fold per proton signal gain was observed for its
ortho resonances at 9.4 T which is equivalent to 28.7%
polarisation (Figure 2). Additionally, a T1 relaxation time
of 138.4 s was recorded.
3 | CONCLUSIONS
In summary, we present a general method for the SABRE
hyperpolarisation of over 30 substituted pyridazines and
signal enhancements of up to 9177-fold at 9.4 T. This is
equivalent to 28.7% polarisation and shows the potential
of this method to dramatically improve signal strength
in magnetic resonance techniques. Monosubstituted
pyridazines perform well and yield good signal enhance-
ments. The steric effect of adding groups into the
3-position is minimised through the substrates' ability to
bind through the N1 atom. The method is able to
tolerate not only electron-rich pyridazines such as
3-methoxypyridazine 3 but also electron poor substrates
such as 3-chloropyridazine 4. Similarly, 4-substituted
pyridazines perform equally well. Interestingly, when the
substrate contains the possibility for multiple binding
modalities, through additional groups such as alcohols or
nitriles, the active catalyst differs from that of the
typical symmetric [Ir(H)2(IMes)(sub)3]Cl. For example,
3-cyanopyridazine 7 formed a catalyst where one of the
equatorial ligands binds through the N1 atom and the
FIGURE 2 Single scan 1H NMR spectra of
d6–23 under (top) thermally polarised conditions
that has been expanded 512× in the vertical
direction and (bottom) after SABRE polarisation
transfer at 70 G using [IrCl (COD)(IMes)]
(5 mM), d6–23 (20 mM) in methanol-d4
10 RAYNER ET AL.
second ligates via the nitrile moiety. This results in lower
SABRE signal enhancements when compared with
pyridazine 1.
The hyperpolarisation of pyridazines becomes more
sensitive when increased steric bulk is placed into the
3- and 6-positions on the aromatic ring. Indeed, when
3,6-dimethylpyridazine 11 is utilised, a 129-fold signal
gain is observed which is a significant reduction when
compared with 3-methylpyridazine 2 (up to 1177-fold sig-
nal gain). Increasing the steric bulk further leads to no
signal enhancements being observed at 298 K, and no
evidence of any hydride containing species could be
detected. This suggests that the NHC-derived catalysts
commonly utilised for SABRE cannot form under the
conditions used here, and therefore, the exploration of
other catalysts could be fruitful.[23,30]
In contrast, 4,5-disubstituted pyridazines all form the
expected symmetric [Ir(H)2(IMes)(sub)3]Cl catalyst and
thus undergo efficacious SABRE. The electronic effect of
changing the functionality does not appear to significantly
impact the resulting signal enhancements after polarisation
transfer. For example, 4,5-dimethoxypyridazine 19 shows
an excellent per proton signal gain for its H3/H6 resonance
of 998-fold, whereas for 4,5-dichloropyridazine, 22 yielded
a signal gain of 878-fold. The best performing substrate
was dimethylester 23 which gave a signal gain of 1647-fold
in conjunction with a T1 relaxation time of over 2 min
at 9.4 T.
Finally, we exemplify the possibility to further
increase the SABRE transfer to substituted pyridazines by
optimisation of the polarisation level of 23. We found that
changing the precatalyst to [IrCl(COD)(SIMes)] a higher
signal gain could be achieved and deuteration of the
methyl esters to give d6–23 ultimately yielded a
polarisation level of >28%. Deuteration of the methyl
esters also extended the T1 relaxation time to 138 s. The
data reported here will allow for the development of
methods to hyperpolarise and detect a range of
pyridazine containing pharmaceutical and agrochemicals
such as the antidepressant minaprine or anticonvulent
SR41378.[3] Next stages will see us consider the effect of
fused ring systems and seek to overcome the challenges
posed by the steric influence of 3,6-disubstituted systems.
ACKNOWLEDGMENTS
The authors would like to acknowledge the following for
supporting this work: The Wellcome Trust (grants
092506 and 098335), the EPSRC (EP/R51181X/1) and the
University of York.
PEER REVIEW
The peer review history for this article is available at
https://publons.com/publon/10.1002/mrc.5152.
ORCID
Peter J. Rayner https://orcid.org/0000-0002-6577-4117
Michael J. Burns https://orcid.org/0000-0002-5569-1270
Elizabeth J. Fear https://orcid.org/0000-0002-0578-
900X
Simon B. Duckett https://orcid.org/0000-0002-9788-
6615
REFERENCES
[1] a] C. Lamberth, J.Heterocycl. Chem. 2017, 54, 2974. b] I. Mohd,
A. Mohammad, J. Bioorg. Chem. 2020, 46, 745. c] T. J. Ritchie,
S. J. F. Macdonald, S. Peace, S. D. Pickett, C. N. Luscombe,
MedChemComm 2012, (3), 1062.
[2] C. Hamdouchi, C. Sanchez-Martinez, J. Gruber, M.
del Prado, J. Lopez, A. Rubio, B. A. Heinz, J. Med. Chem. 2003,
46, 4333.
[3] C. G. Wermuth, MedChemComm 2011, 2, 935.
[4] B. M. Fox, K. Iio, K. Li, R. Choi, T. Inaba, S. Jackson, S.
Sagawa, B. Shan, M. Tanaka, A. Yoshida, F. Kayser, Bioorg.
Med. Chem. Lett. 2010, 20, 6030.
[5] B. Dyck, S. Markison, L. Zhao, J. Tamiya, J. Grey, M. W.
Rowbottom, M. Zhang, T. Vickers, K. Sorensen, C. Norton, J.
Wen, C. E. Heise, J. Saunders, P. Conlon, A. Madan, D.
Schwarz, V. S. Goodfellow, J. Med. Chem. 2006, 49, 3753.
[6] a] K. V. Kovtunov, E. V. Pokochueva, O. G. Salnikov, S. F.
Cousin, D. Kurzbach, B. Vuichoud, S. Jannin, E. Y.
Chekmenev, B. M. Goodson, D. A. Barskiy, I. V. Koptyug,
Chem. – Asian J. 2018, 13, 1857. b] P. Nikolaou, B. M.
Goodson, E. Y. Chekmenev, Chemistry 2015, 21, 3156.
[7] a] S. A. Colebrooke, S. B. Duckett, J. A. B. Lohman, R.
Eisenberg, Chem. – Eur. J. 2004, 10, 2459. b] C. Godard, S. B.
Duckett, S. Polas, R. Tooze, A. C. Whitwood, Dalton Trans.
2009, 38, 2496. c] C. Godard, J. Lopez-Serrano, M. D. Galvez-
Lopez, M. Rosello-Merino, S. B. Duckett, I. Khazal, A. Lledos,
A. C. Whitwood, Magn. Reson. Chem. 2008, 46, S107. d] D. J.
Fox, S. B. Duckett, C. Flaschenriem, W. W. Brennessel, J.
Schneider, A. Gunay, R. Eisenberg, Inorg. Chem. 2006, 45,
7197. e] J. López-Serrano, S. B. Duckett, A. Lledós, J. Am.
Chem. Soc. 2006, 128, 9596. f] I. Atheaux, F. Delpech, B.
Donnadieu, S. Sabo-Etienne, B. Chaudret, K. Hussein, J.-C.
Barthelat, T. Braun, S. B. Duckett, R. N. Perutz, Organometal-
lics 2002, 21, 5347. g] P. D. Morran, S. A. Colebrooke, S. B.
Duckett, J. A. B. Lohman, R. Eisenberg, J. Chem. Soc., Dalton
Trans. 1998, 22, 3363.
[8] a] P. M. Richardson, W. Iali, S. S. Roy, P. J. Rayner, M. E.
Halse, S. B. Duckett, Chem. Sci. 2019, 10, 10607. b] N. Eshuis,
B. J. A. van Weerdenburg, M. C. Feiters, F. P. J. T. Rutjes, S. S.
Wijmenga, M. Tessari, Angew. Chem., Int. Ed. 2015, 54, 1481.
c] L. S. Lloyd, R. W. Adams, M. Bernstein, S. Coombes, S. B.
Duckett, G. G. R. Green, R. J. Lewis, R. E. Mewis, C. J. Sleigh,
J. Am. Chem. Soc. 2012, 134, 12904.
[9] S. Fain, M. L. Schiebler, D. G. McCormack, G. Parraga,
J. Magn. Reson. Imaging 2010, 32, 1398.
[10] a] E. Cavallari, C. Carrera, M. Sorge, G. Bonne, A. Muchir, S.
Aime, F. Reineri, Sci. Rep. 2018, 8, 8366. b] H. Gutte, A. E.
Hansen, H. H. Johannesen, A. E. Clemmensen, J. H.
Ardenkjar-Larsen, C. H. Nielsen, A. Kjar, Am J Nucl Med Mol
Imaging 2015, 5, 548. c] T. Harris, H. Degani, L. Frydman,
RAYNER ET AL. 11
NMR Biomed. 2013, 26, 1831. d] T. H. Witney, M. I. Kettunen,
K. M. Brindle, J. Biol. Chem. 2011, 286, 24572. e] C. von
Morze, P. E. Z. Larson, S. Hu, K. Keshari, D. M. Wilson, J. H.
Ardenkjaer-Larsen, A. Goga, R. Bok, J. Kurhanewicz, D. B.
Vigneron, J. Magn. Reson. Imaging 2011, 33, 692. f] Y.-F. Yen,
S. J. Kohler, A. P. Chen, J. Tropp, R. Bok, J. Wolber, M. J.
Albers, K. A. Gram, M. L. Zierhut, I. Park, V. Zhang, S. Hu,
S. J. Nelson, D. B. Vigneron, J. Kurhanewicz, H. A. A. M.
Dirven, R. E. Hurd, Magn. Res. Med. 2009, 62, 1.
[11] a] T. G. Walker, W. Happer, Rev. Mod. Phys. 1997, 69, 629. b]
S. Appelt, A. B.-A. Baranga, C. Erickson, M. Romalis, A.
Young, W. Happer, Phys. Rev. a 1998, 58, 1412.
[12] a] G. Zhang, C. Hilty, Magn. Reson. Chem. 2018, 56, 566. b] T.
Maly, G. T. Debelouchina, V. S. Bajaj, K.-N. Hu, C.-G. Joo,
M. L. Mak-Jurkauskas, J. R. Sirigiri, P. C. van der Wel, J.
Herzfeld, R. J. Temkin, J. Chem. Phys. 2008, 128, 02B611. c]
K. R. Keshari, D. M. Wilson, Chem. Soc. Rev. 2014, 43, 1627.
[13] a] C. R. Bowers, D. P. Weitekamp, J. Am, Chem. Soc. 1987,
109, 5541. [b]C. R. Bowers, D. P. Weitekamp, Phys. Rev. Lett.
1986, 57, 2645.
[14] R. W. Adams, J. A. Aguilar, K. D. Atkinson, M. J. Cowley,
P. I. P. Elliott, S. B. Duckett, G. G. R. Green, I. G. Khazal, J.
López-Serrano, D. C. Williamson, Science 2009, 323, 1708.
[15] a] M. J. Cowley, R. W. Adams, K. D. Atkinson, M. C. R.
Cockett, S. B. Duckett, G. G. R. Green, J. A. B. Lohman, R.
Kerssebaum, D. Kilgour, R. E. Mewis, J. Am, Chem. Soc. 2011,
133, 6134. b] P. J. Rayner, P. Norcott, K. M. Appleby, W. Iali,
R. O. John, S. J. Hart, A. C. Whitwood, S. B. Duckett, Nat.
Commun. 2018, 9, 4251.
[16] R. W. Adams, S. B. Duckett, R. A. Green, D. C. Williamson,
G. G. R. Green, J. Chem. Phys. 2009, 131, 194505.
[17] a] P. J. Rayner, S. Duckett, Angew. Chem., Int. Ed. 2018, 57,
6742. b] J.-B. Hövener, A. N. Pravdivtsev, B. Kidd, C. R.
Bowers, S. Glöggler, K. V. Kovtunov, M. Plaumann, R. Katz-
Brull, K. Buckenmaier, A. Jerschow, F. Reineri, T. Theis, R. V.
Shchepin, S. Wagner, P. Bhattacharya, N. M. Zacharias, E. Y.
Chekmenev, Angew. Chem., Int. Ed. 2018, 57, 11140.
[18] K. M. Appleby, R. E. Mewis, A. M. Olaru, G. G. R. Green,
I. J. S. Fairlamb, S. B. Duckett, Chem. Sci. 2015, 6, 3981.
[19] P. J. Rayner, M. J. Burns, A. M. Olaru, P. Norcott, M. Fekete,
G. G. R. Green, L. A. R. Highton, R. E. Mewis, S. B. Duckett,
Proc. Natl. Acad. Sci. U. S. A. 2017, 114, E3188.
[20] S. S. Roy, P. Norcott, P. J. Rayner, G. G. R. Green, S. B.
Duckett, Angew. Chem. Int. Ed. 2016, 128, 15871.
[21] a] S. S. Roy, P. Norcott, P. J. Rayner, G. G. R. Green, S. B.
Duckett, Chem. - Eur. J. 2017, 23, 10496. b] S. S. Roy, P. J.
Rayner, M. J. Burns, S. B. Duckett, J. Chem. Phys. 2020, 152,
014201. c] J. F. P. Colell, A. W. J. Logan, Z. Zhou, R. V.
Shchepin, D. A. Barskiy, G. X. Ortiz, Q. Wang, S. J.
Malcolmson, E. Y. Chekmenev, W. S. Warren, T. Theis,
J. Phys. Chem. C. 2017, 121, 6626.
[22] R. V. Shchepin, M. L. Truong, T. Theis, A. M. Coffey, F. Shi,
K. W. Waddell, W. S. Warren, B. M. Goodson, E. Y.
Chekmenev, J. Phys. Chem. Lett. 2015, 6, 1961.
[23] J. Colell, A. W. J. Logan, Z. Zhou, J. R. Lindale, R. Laasner, R.
Shchepin, E. Chekmenev, V. Blum, W. S. Warren, S. J.
Malcolmson, T. Theis, Chem. Commun. 2020, 56, 9336.
[24] R. E. Mewis, R. A. Green, M. C. R. Cockett, M. J. Cowley, S. B.
Duckett, G. G. R. Green, R. O. John, P. J. Rayner, D. C.
Williamson, J. Phys, Chem. B 2015, 119, 1416.
[25] W. Iali, P. J. Rayner, A. Alshehri, A. J. Holmes, A. J.
Ruddlesden, S. B. Duckett, Chem. Sci. 2018, 9, 3677.
[26] a] D. K. Heldmann, J. Sauer, Tetrahedron Lett. 1997, 38, 5791.
b] J. Cioslowski, J. Sauer, J. Hetzenegger, T. Karcher, T.
Hierstetter, J. Am. Chem. Soc. 1993, 115, 1353. c] M. D. Helm,
J. E. Moore, A. Plant, J. P. A. Harrity, Angew. Chem., Int. Ed.
2005, 44, 3889.
[27] A. M. Olaru, A. Burt, P. J. Rayner, S. J. Hart, A. C. Whitwood,
G. G. R. Green, S. B. Duckett, Chem. Commun. 2016, 52,
14482.
[28] D. A. Barskiy, A. N. Pravdivtsev, K. L. Ivanov, K. V. Kovtunov,
I. V. Koptyug, Phys. Chem. Chem. Phys. 2016, 18, 89.
[29] a] B. J. A. van Weerdenburg, S. Gloggler, N. Eshuis, A. H. J.
Engwerda, J. M. M. Smits, R. de Gelder, S. Appelt, S. S.
Wymenga, M. Tessari, M. C. Feiters, B. Blumich, F. P. J. T.
Rutjes, Chem. Commun. 2013, 49, 7388. b] L. S. Lloyd, A.
Asghar, M. J. Burns, A. Charlton, S. Coombes, M. J. Cowley,
G. J. Dear, S. B. Duckett, G. R. Genov, G. G. R. Green, L. A. R.
Highton, A. J. J. Hooper, M. Khan, I. G. Khazal, R. J. Lewis,
R. E. Mewis, A. D. Roberts, A. J. Ruddlesden, Catal. Sci.
Technol. 2014, 4, 3544.
[30] a] W. Iali, G. G. R. Green, S. J. Hart, A. C. Whitwood, S. B.
Duckett, Inorg. Chem. 2016, 55, 11639. b] A. J. Holmes, P. J.
Rayner, M. J. Cowley, G. G. R. Green, A. C. Whitwood, S. B.
Duckett, Dalton Trans. 2015, 44, 1077.
SUPPORTING INFORMATION
Additional supporting information may be found online
in the Supporting Information section at the end of this
article.
How to cite this article: Rayner PJ, Burns MJ,
Fear EJ, Duckett SB. Steric and electronic effects
on the 1H hyperpolarisation of substituted
pyridazines by signal amplification by reversible
exchange. Magn Reson Chem. 2021;1–12. https://
doi.org/10.1002/mrc.5152
12 RAYNER ET AL.
